GigCapital7 (GIGGU) Prices Downsized $200M IPO
by Nicholas Alan Clayton on 2024-08-29 at 9:14am

GigCapital7 announced the pricing of its downsized $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GIGGU”, Thursday, August 29, 2024.

The new SPAC intends to combine with a technology target in the AI, medtech, sustainability, and broader TMT sectors.

GigCapital7’s sponsor team is to be led by Chairman and Chief Executive Officer, Dr. Avi S. Katz, alongside Chief Financial Officer, Christine Marshall. Dr. Raluca Dinu, Raanan I. Horowitz, Karen Rogge, Professor Darius Moshfeghi, and Ambassador Adrian Zuckerman are to serve on the SPAC’s Board of Directors.

Total SPAC deal count for 2024 year-to-date is now 29. This offering is expected to close on Friday, August 30, 2024.


Craft Capital Management and EF Hutton are serving as joint book-running managers for the offering. DLA Piper LLP is serving as Issuer’s Counsel with Lucosky Brookman LLP serving as Underwriter’s Counsel. BPM LLC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2025-04-23 at 6:13pm

New Providence Acquisition Corp. III (NASDAQ:NPACU) announced the pricing of its $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NPACU”, Thursday, April 24, 2025. The new SPAC aims to combine with a consumer target that has the potential to generate attractive risk-adjusted returns. New Providence III’s...

by Nicholas Alan Clayton on 2025-04-23 at 3:59pm

Cantor Equity Partners Inc. (NASDAQ:CEP) has entered into a definitive agreement to combine with Twenty One Capital at an enterprise value of $3.6 billion, or 1x its future net asset value (NAV). Twenty One Capital aims to secure a sizeable Bitcoin holding and leverage it for financial services products as well as Bitcoin-focused media offerings....

by Nicholas Alan Clayton on 2025-04-23 at 12:41pm

Voyager (NASDAQ:VACH) has signed a definitive agreement to combine with biotech firm VERAXA at an enterprise value of $1.38 billion. Heidelberg, Germany-based VERAXA is developing cancer treatments with its most advanced candidate targeting acute myeloid leukemia (AML). The combined company is expected to trade on the Nasdaq under the symbol “VERX” once the deal is...

by Nicholas Alan Clayton on 2025-04-23 at 8:22am

At the SPAC of Dawn SPACs announced two more business combinations and priced a IPO in the past 24 hours showing that activity is going to continue apace regardless of the present market volatility. Another major deal is rumored in the wind with Cantor Equity Partners I (NASDAQ:CEPO) reportedly nearing a major merger that would...

by Kristi Marvin on 2025-04-22 at 5:42pm

Texas Ventures Acquisition III Corp (NASDAQ:TVACU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TVACU”, Wednesday, April 23, 2025. The new SPAC’s primary search focus will be on industrial technology, specifically companies implementing advanced technologies including software, mobile and IoT applications,...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved